38112003: un (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\un

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
un	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely selinexor 20 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely luspatercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely luspatercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely luspatercept 75 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely luspatercept 75 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Vaccine product containing only Neisseria meningitidis serogroup C capsular polysaccharide conjugated antigen (medicinal product)	Count of active ingredient	False	un	Inferred relationship	Some
Vaccine product containing only Neisseria meningitidis serogroup C antigen (medicinal product)	Count of active ingredient	False	un	Inferred relationship	Some
Polyestradiol only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Fostemsavir only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Fostemsavir only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely fostemsavir 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely mebendazole 500 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely triclabendazole 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Benznidazole 100 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Benznidazole 100 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Benznidazole 12.5 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Benznidazole 12.5 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Triclabendazole 250 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Triclabendazole 250 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely benzylpenicillin (as benzylpenicillin potassium) 5 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely benzylpenicillin (as benzylpenicillin potassium) 5 million unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cedazuridine 100 mg and decitabine 35 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Cedazuridine 100 mg and decitabine 35 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Miltefosine 50 mg oral capsule	Count of base of active ingredient	False	un	Inferred relationship	Some
Miltefosine 50 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Amphotericin B liposome 50 mg powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Amphotericin B liposome 50 mg powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely ombitasvir 12.5 milligram and paritaprevir 75 milligram and ritonavir 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	3
Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ledipasvir 90 milligram and sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Ledipasvir 45 mg and sofosbuvir 200 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely sofosbuvir 400 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely glecaprevir 100 milligram and pibrentasvir 40 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	2
Brexucabtagene autoleucel only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only brexucabtagene autoleucel in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely afatinib (as afatinib dimaleate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Agomelatine 25 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Agomelatine 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Antipyrine 50 mg/mL ear drops solution	Count of base of active ingredient	False	un	Inferred relationship	Some
Antipyrine 50 mg/mL ear drops solution	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Bisacodyl 2 mg/mL rectal suspension	Count of base of active ingredient	False	un	Inferred relationship	Some
Bisacodyl 2 mg/mL rectal suspension	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing only agomelatine in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only phenazone in otic dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Cinnarizine 25 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Cinnarizine 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Brivaracetam 75 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Brivaracetam 75 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Brivaracetam 50 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Brivaracetam 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Brivaracetam 25 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Brivaracetam 25 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely brivaracetam 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely brivaracetam 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Brivaracetam 100 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Brivaracetam 100 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Brigatinib 30 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Brigatinib 30 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely brigatinib 180 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely brigatinib 180 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely brigatinib 90 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely brigatinib 90 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Binimetinib 15 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Binimetinib 15 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Baricitinib 2 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Baricitinib 2 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Baricitinib 4 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some

Start Previous Page 110 of 217 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
615211000077111	un (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
771016011	One (qualifier value)	en	Fully specified name	Inactive	Only initial character case insensitive (core metadata concept)	SNOMED CT core